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Abstract  
Sheep scab represents a significant burden for the national sheep industry and a serious welfare issue 
for diseased animals. Although different treatment options are available and despite tackling of this 
disease being a top priority for the industry, sheep scab is currently widely spread within the UK and 
its control still represent a significant challenge for all the parties involved. 
This article provides an overview of sheep scab, focusing on the established knowledge available for 
both clinical and subclinical disease. Recent advancement in the diagnosis of the disease are also 
presented, with an emphasis on the added value and practical use of a blood test for diagnosis of the 
subclinical disease and for its use in monitoring flock exposure to the parasite. Currently available and 
future options for treatment and disease control are discussed, especially in the light of the challenge 
posed by the development of drug resistance. 
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Introduction 
Sheep scab is the most important ectoparasitic disease of sheep in the UK and it represents a 
significant threat to both animal welfare and farm economics. Despite active legislation, sheep scab is 
currently endemic in the UK (Losson 2012), with a total of 411 notifications to the Animal and Plant 
Health Agency (APHA) between 2012 and 20171. The earliest record of the disease in this country is 
from the 13th century (Lewis 2013), being successfully eradicated once and subsequently reintroduced 
20 years later. Recent updates in legislation have made sheep scab a notifiable disease in Scotland, 
while for England and Wales, it is a criminal offence to move infested animals or fail to treat sheep 
visibly affected by scab. 
Overview of the disease 
Sheep scab is an allergic dermatitis caused by the non-burrowing ectoparasitic mite Psoroptes ovis. 
The disease is transmitted primarily by direct contact and is host specific, with the parasite spending 
its entire life-cycle on the sheep (van den Broek and Huntley 2003). The main source of the disease 
are infested neighbouring farms, purchased or returning (away-wintering, common grazing) animals, 
shared equipment and strays. Mites, however, can survive off the sheep and remain infective for up 
to 16 days (O'Brien, Gray et al. 1994), making fences and handling facilities a possible alternative 
source of infestation. The clinical signs are related to the faecal deposition of allergens on the skin of 
the host, which causes an intense inflammatory reaction, with marked pruritus, self-trauma, severe 
dermatitis, alopecia (Figure 1) and considerable weight loss (Kirkwood 1986). Lesions are localised 
initially on the withers, progressively extend to the lumbar area and if left untreated, can quickly cover 
the entire body. The subclinical phase (Figure 2) can persist for up to 8 months in naturally occurring 
disease, with absent or very limited symptoms, like head tossing, restlessness, wool staining and mild 
pruritus. These animals represent a challenge in clinical diagnosis and the most likely source of 
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infestation to other flocks. An interesting feature of the disease seems to be its seasonal pattern, with 
the majority of the outbreaks noticed in the winter months (French, Berriatua et al. 1999). 
Figure 1 – Skin lesions typically seen in a clinical case of sheep scab: severe dermatitis with thickened 
erythematous skin, alopecia, dry scales and crusts. 
Figure 2 – A lamb 6 weeks post-infestation with P. ovis mites showing very mild wool staining on the withers.  
Diagnosis of sheep scab 
Diagnosis of sheep scab was traditionally based on clinical observations and identification of mites 
(Figure 3) in skin scrapings. Skin scrapings are taken using a scalpel blade at the edge of the active 
lesions, the scraping being continued until enough material is available, which is then transferred onto 
a microscope slide with a drop of lubricant oil and observed under low magnification (x100). This 
approach, although representing the conventional method for diagnosis of clinical disease, is often 
unable to detect subclinical infestation or sub-clinical carrier as lesions are not easily identifiable and 
mites numbers might be low. Consequently, by the time P. ovis mites are detected, they have often 
already spread to the rest of the flock. 
Figure 3 - Psoroptes ovis mite identified at microscope examination (x100 maginfication). 
The recent development by the Moredun Research Institute of a serum indirect ELISA for the detection 
of antibodies specific to a mite allergen (Pso o 2) has proven a highly sensitive diagnostic test for both 
clinical and subclinical sheep scab (Nunn, Burgess et al. 2011). The blood test can be very valuable to 
exclude other common diseases causing similar clinical signs (e.g. pruritus and wool loss), like other 
ectoparasites (mainly lice and other manges), photosensitization or other dermatitis (fleece-rot or 
dermatophilosis). Although skin scraping is still considered the routine technique for clinically evident 
sheep scab, it is relatively time consuming and requires a skilled operator for microscopic 
identification of ectoparasites. In this case, all the animals showing clinical signs of the disease or a 
proportion of the affected ones can be sampled.  
The ELISA test can also reliably diagnose sheep scab as early as 2 weeks post-infestation, where at 
least half (6/11) of the animals showed elevated serum IgG responses, while detection of mites using 
skin scraping would only achieve below 20% rate (2/11 animals) (Burgess, Innocent et al. 2012). The 
test, therefore, represents a significant improvement in the diagnosis of the subclinical disease, which 
might not have been possible due to the lack of clinical signs and high percentage of false negative 
skin scraping results. This test can also be applied as a screening tool when animals are quarantined 
after being bought in, returning from away wintering or rented to other farms for mating. In this case, 
a suggested sampling of 12 animals, coupled with flock management data, would provide valuable 
information on the disease status of the flock and its exposure to the parasite2. 
At the same time, there has been a growing need for low-cost, rapid and reliable diagnostic tests in 
veterinary medicine. In the context of sheep scab, the time from sample collection to result 
acquisition and the cost of the test might represent an issue. Although commercially available, the 
test is usually run once a week for a cost of £6/sample on a minimum of 12 animals per flock. In the 
case of an outbreak, the farmer would either have to wait potentially for a whole week or might 
decide to treat before having received the results. Furthermore, due to the antiparasitic drugs being 
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relatively low-cost, the expenses of blank treatments would likely be cheaper than the overall cost of 
testing (including labour cost for gathering animals twice) (Nieuwhof and Bishop 2005). It is obvious 
that having this assay as a low-cost POC test would further improve the diagnosis and appropriate 
usage of anti-parasitic drugs for sheep scab. Research is currently undergoing to transfer this test 
into a point-of-care assay, based on the exploitation of modern engineering technologies which 
could provide a low-cost and rapid “pen-side” test for sheep scab (Busin, Burgess et al. 2015). 
Options for treatment and control of the disease 
At present, two classes of antiparasitic drugs are available for treatment and control of sheep scab: 
the organophosphapte (OP) dip diazinon and the injectable macrocyclic lactones (ML). The licensed 
antiparasitic drug available in the UK are reported in Table 1. 
Table 1 – Licensed antiparasitic drugs for sheep scab treatment. OP: Organophosphate. ML: macrocyclic 
lactones. (Updated March 2018). 
Category Active 
principle 
Commercial name Treatment 
regime 
Persistency Meat 
withdrawal 
OP plunge 
dip 
Diazinon Osmonds Gold 
Fleece 
Paracide 62 
Dip animals 
for one 
minute with 
head dipped 
twice 
Up to 4 weeks 
protection 
49 days 
 
70 days 
ML 
injectables 
Ivermectin Ecomectin 1% 
Ivomec Classic 
Noromectin 1% 
Panomec 
Paramectin 
Premadex 1% 
Qualimec 10mg/ml 
2 injections SC 
7 days apart 
 
Contact 
between 
treated and 
uninfected 
sheep to be 
avoided for 
14days 
37-42 days 
ML 
injectables 
Doramectin Dectomax 
10mg/ml 
1 injection IM Contact 
between 
treated and 
uninfected 
sheep to be 
avoided for 
14days 
70 days 
ML 
injectables 
Moxidectin Cydectin 1% 2 injections SC 
10 days apart 
28 days 
Contact 
between 
treated and 
uninfected 
sheep to be 
avoided for 
22days 
70 days 
ML 
injectables 
Moxidectin 
LA 2% 
Cydectin 20mg/ml 
LA 
1injection SC 
(base of the 
ear) 
60 days 104 days 
 
The choice of treatment should be tailored to the individual farm and specific situation, taking into 
consideration some important points. Plunge dipping has some advantages over injectable 
macrocyclic lactones as they kill mites within 24 hours and provide residual activity for several weeks. 
They also control other ectoparasites, like blowfly strike, headfly, lice, ticks and keds. Plunge dipping, 
however, requires a special license for administration, has relevant issues for disposal and is usually 
more labour intense. It should also be avoided in heavily pregnant sheep and in flocks with CLA, 
erysipelosis and ORF issues.  
Macrocyclic lactones can be used to control nematodes as well, which, depending on the time of the 
year, could be regarded as a desirable or non-favourable option. They are safer for the operator and 
less stressful for the sheep. However, they take up to 7 days to kill mites (with persistency of clinical 
signs during this time) and can have prolonged withdrawal times. 
Irrespective of the treatment chosen, all sheep must be gathered and correctly treated3. Handling 
pens, equipment and fields should also be considered contaminated for at least 17days after removal 
of infested sheep. 
The option for control, at present, rely on a combination of antiparasitic drugs and biosecurity 
measures, with the aim placed on avoiding introducing the disease in the first place. Strict biosecurity 
should be observed, mainly through quarantine (and possibly treatment) of all incoming animals, 
maintenance of good fencing and disinfection of vehicles and equipment. The sheep scab ELISA has 
also been advocated to monitor flock status and to aid selective treatment to seropositive flocks 
(Jacober, Ochs et al. 2006). Furthermore, due to the highly contagious nature of this disease and its 
methods of transmission, it is important to consider that control options should be coordinated at a 
regional (or potentially national) level, with veterinary involvement playing an essential role in 
coordination and training campaigns. 
Moxidectin resistance 
Very recently, the first report of resistance to injectable moxidectin has been published. Following 
reported treatment failure from four farms, mites collected were exposed to different concertation 
of the compound and, even when exposed to very high concentrations, they were able to survive 
(Doherty, Burgess et al. 2018). Furthermore, the possibility of cross-resistance to the other ML 
compounds represent a likely possibility. However, these findings should not have come as a surprise. 
The use of injectable ML for management of sheep scab is still predominant among farmers (Bisdorff 
and Wall 2008) as well as being among the most commonly used drugs for nematode control (Morgan, 
Hosking et al. 2012). In light of these problematics, there is definitely no indications for indiscriminate 
prophylactic treatments. On the contrary, an approach based on a wider use of diagnostics and a 
better collaboration between farmers vet and the industry should be advocated for effective control 
of this disease. 
Alternative methods for control 
Alternative methods for control, which are currently under study, include the development of 
vaccines, genetic selection for resistance and the use of biological control (like nematodes, bacteria, 
fungi or viruses). Sheep infested and successfully treated tend to have lower number of mites and 
reduced lesions size, which suggest there is development of acquired immunity following infestation 
(Bates 2000). Candidate antigens which could be included in a commercial vaccine and provide 
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protective immunity to the disease are currently evaluated, with some promising results showing a 
reduction in lesion size and parasite numbers in vaccinated animals (Burgess, Nunn et al. 2016).  
Furthermore, research is ongoing to test other chemicals, like the growth regulators (Dunn, Prickett 
et al. 2016) in order to expand the class of treatment available or to evaluate the acaridicidal effect of 
fungal pathogens (Metarhizium anisopliae) to control mites within the sheep (Wall 2007). 
Conclusions  
Through a better understanding of the pathogenesis and an additional diagnostic test for the disease, 
the tools available to combat sheep scab have now considerably broadened. Research is ongoing in 
multiple directions to allow for further improvements in the control of the disease and the results are 
very encouraging. As for many other animal diseases, the pillar for the effective control is thorough a 
genuine and close collaboration between farmers, vets, scientists and the industry to identify practical 
and effective solutions to solve a shared problem. 
Key points 
 Sheep scab, caused by the ectoparasite Psoroptes ovis, is an allergic dermatitis which can 
present as clinical or subclinical disease. 
 Subclinical disease represent the most challenging for correct diagnosis and the likely source 
of infection to other flocks. 
 The recent development and commercialization of a blood test ELISA has allowed a substantial 
improvement in diagnosis of the subclinical disease. The test can also be used for monitoring 
purposes. 
 The available options for control/treatment have not changed significantly, but the recent 
report of moxidectin resistance poses questions on the sustainability of the current control 
methods. 
 Alternative methods for control are currently under investigation (vaccination, genetic 
selection and alternative compounds) which would increase our options to reduce the impact 
of this disease on the national flock. 
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